Response
- PMID: 29506059
- PMCID: PMC7446236
- DOI: 10.1093/jnci/djy026
Response
Comment on
-
Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers.J Natl Cancer Inst. 2018 Jun 1;110(6):581-587. doi: 10.1093/jnci/djx240. J Natl Cancer Inst. 2018. PMID: 29281040 Free PMC article.
-
RE: Effectiveness of Pharmaceutical Smoking Cessation Aids in a Nationally Representative Cohort of American Smokers.J Natl Cancer Inst. 2018 Oct 1;110(10):1141. doi: 10.1093/jnci/djy025. J Natl Cancer Inst. 2018. PMID: 29506226 Free PMC article. No abstract available.
References
-
- Chia SK, Speers CH, D'Yachkova Y, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer. 2007;1105:973–979. - PubMed
-
- Tindle HA, Greevy RA.. Smoking cessation pharmacotherapy, even without counseling, remains a cornerstone of treatment. J Natl Cancer Inst. 2018;1106:545–546. - PubMed
-
- Motschman CA, Gass JC, Wray JM, et al. Selection criteria limit generalizability of smoking pharmacotherapy studies differentially across clinical trials and laboratory studies: A systematic review on varenicline. Drug Alcohol Depend. 2016;169:180–189. - PubMed
-
- Imai K, King G, Stuart E.. Misunderstandings among experimentalists and observationalists about causal inference. J Royal Stat Soc. 2008;171(part 2):481–502.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical